Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

NCT03719066 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
181
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators